BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37225693)

  • 1. Hyperphosphorylated PTEN exerts oncogenic properties.
    van Ree JH; Jeganathan KB; Fierro Velasco RO; Zhang C; Can I; Hamada M; Li H; Baker DJ; van Deursen JM
    Nat Commun; 2023 May; 14(1):2983. PubMed ID: 37225693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer.
    Zhao C; Tao T; Yang L; Qin Q; Wang Y; Liu H; Song R; Yang X; Wang Q; Gu S; Xiong Y; Zhao D; Wang S; Feng D; Jiang WG; Zhang J; He J
    Cancer Lett; 2019 Jul; 453():107-121. PubMed ID: 30930234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cells.
    Obeidat M; Li L; Ballermann BJ
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F623-33. PubMed ID: 25007873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments.
    Ohkawa K; Asakura T; Tsukada Y; Matsuura T
    Int J Oncol; 2017 Jun; 50(6):2180-2190. PubMed ID: 28498467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the PTEN tail regulates protein stability and function.
    Vazquez F; Ramaswamy S; Nakamura N; Sellers WR
    Mol Cell Biol; 2000 Jul; 20(14):5010-8. PubMed ID: 10866658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.
    Nakahata S; Ichikawa T; Maneesaay P; Saito Y; Nagai K; Tamura T; Manachai N; Yamakawa N; Hamasaki M; Kitabayashi I; Arai Y; Kanai Y; Taki T; Abe T; Kiyonari H; Shimoda K; Ohshima K; Horii A; Shima H; Taniwaki M; Yamaguchi R; Morishita K
    Nat Commun; 2014 Feb; 5():3393. PubMed ID: 24569712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
    J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors.
    Millis SZ; Ikeda S; Reddy S; Gatalica Z; Kurzrock R
    JAMA Oncol; 2016 Dec; 2(12):1565-1573. PubMed ID: 27388585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN Mouse Models of Cancer Initiation and Progression.
    Lee YR; Pandolfi PP
    Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31570383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis.
    Lee MS; Jeong MH; Lee HW; Han HJ; Ko A; Hewitt SM; Kim JH; Chun KH; Chung JY; Lee C; Cho H; Song J
    Nat Commun; 2015 Jul; 6():7769. PubMed ID: 26183061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal elevated PTEN expression in the mouse antrum of a model of GIST Kit(K641E/K641E).
    Deneubourg L; Ralea S; Gromova P; Parsons R; Vanderwinden JM; Erneux C
    Cell Signal; 2011 Nov; 23(11):1857-68. PubMed ID: 21757001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation.
    Sharma M; Chuang WW; Sun Z
    J Biol Chem; 2002 Aug; 277(34):30935-41. PubMed ID: 12063252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation.
    Bilir B; Osunkoya AO; Wiles WG; Sannigrahi S; Lefebvre V; Metzger D; Spyropoulos DD; Martin WD; Moreno CS
    Cancer Res; 2016 Mar; 76(5):1112-21. PubMed ID: 26701805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.